Utama › Leukemia Limfoblastik Akut › Tennessee
Kajian klinikal Leukemia Limfoblastik Akut di Tennessee
22 kajian untuk Leukemia Limfoblastik Akut sedang mencari peserta di lokasi di Tennessee.
Bandar di Tennessee
Teks kajian rasmi (Bahasa Inggeris)
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- TriStar Bone Marrow Transplant / Sarah Cannon Transplant & Cellular Therapy, Nashville
Mengambil pesertaFasa 2
6 Months · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06514794Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
- St. Jude Children's Research Hospital, Memphis
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06819475Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
- St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 1
Sehingga umur 21 · Semua jantina · Dikemas kini 31 Ogo 2026 · NCT04881240CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
- St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 1
Sehingga umur 21 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07257419The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- East Tennessee Childrens Hospital, Knoxville
- Saint Jude Children's Research Hospital, Memphis
- The Children's Hospital at TriStar Centennial, Nashville
- dan 1 lagi
Mengambil pesertaFasa 1/2
Sehingga umur 22 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04726241A Study of CTD402 in T-ALL/LBL Patients
- Sarah Cannon Research Insitute, Nashville
Mengambil pesertaFasa 1/2
Umur 1 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT07070219Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
- St. Jude Children's Research Hospital, Memphis
Mengambil peserta
Umur 20 hingga 50 · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT07191119Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
- Vanderbilt University Medical Center, Nashville
Mengambil pesertaKajian pemerhatian
1 Day – 17 Years · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT06274788Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
- St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 2
Umur 1 hingga 18 · Semua jantina · Dikemas kini 16 Jul 2026 · NCT06533748Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
- St. Jude Children's Research Hospital, Memphis
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jul 2026 · NCT06747910Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 4
Umur 1 hingga 18 · Semua jantina · Dikemas kini 14 Jul 2026 · NCT06289673Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Research Site, Franklin
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT07109219A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- St. Jude Childrens Research Hospital, Memphis
- Vanderbilt University, Nashville
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
- St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Jun 2026 · NCT07228741Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
- St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 1/2
Sehingga umur 21 · Semua jantina · Dikemas kini 3 Jun 2026 · NCT04195347CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
- St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 1
Sehingga umur 21 · Semua jantina · Dikemas kini 19 Mei 2026 · NCT06777979CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
- St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 2
Sehingga umur 21 · Semua jantina · Dikemas kini 25 Mac 2026 · NCT06847269A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- TriStar Centennial Medical Center, Nashville
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 24 Mac 2026 · NCT04988555CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies
- St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 1
Sehingga umur 21 · Semua jantina · Dikemas kini 23 Jan 2026 · NCT06326463Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 2
Umur 10 hingga 30 · Semua jantina · Dikemas kini 4 Dis 2025 · NCT05194397HPC Offered for PRESERVE Expansion
- Tristar Centennial Medical Center, Nashville
Mengambil pesertaKajian pemerhatian
Umur 12 hingga 80 · Semua jantina · Dikemas kini 28 Ogo 2025 · NCT07145411Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- St. Jude Children's Research Hospital, Memphis
Mengambil pesertaFasa 1
Umur 1 hingga 21 · Semua jantina · Dikemas kini 6 Dis 2024 · NCT05476770Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.